BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25879391)

  • 1. Past, present, and future for biologic intervention in atopic dermatitis.
    Howell MD; Parker ML; Mustelin T; Ranade K
    Allergy; 2015 Aug; 70(8):887-96. PubMed ID: 25879391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New era of biologic therapeutics in atopic dermatitis.
    Guttman-Yassky E; Dhingra N; Leung DY
    Expert Opin Biol Ther; 2013 Apr; 13(4):549-61. PubMed ID: 23323893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the T Helper 2 Inflammatory Axis in Atopic Dermatitis.
    Moreno AS; McPhee R; Arruda LK; Howell MD
    Int Arch Allergy Immunol; 2016; 171(2):71-80. PubMed ID: 27846627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
    Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
    Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atopic dermatitis: recent insight on pathogenesis and novel therapeutic target.
    D'Auria E; Banderali G; Barberi S; Gualandri L; Pietra B; Riva E; Cerri A
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):98-108. PubMed ID: 27007830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
    Shaw M; Morrell DS; Goldsmith LA
    Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itch in Atopic Dermatitis.
    Kido-Nakahara M; Furue M; Ulzii D; Nakahara T
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):113-122. PubMed ID: 27886901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of psoriasis and atopic dermatitis guidelines-an argument for aggressive atopic dermatitis management.
    Lohman ME; Lio PA
    Pediatr Dermatol; 2017 Nov; 34(6):739-742. PubMed ID: 28944965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
    Beattie PE; Lewis-Jones MS
    Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
    Yanes DA; Mosser-Goldfarb JL
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging therapeutic options for atopic dermatitis: beyond TIMs.
    Conner ER; Beck LA
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):275-81. PubMed ID: 16822379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic Skin Care and Topical Therapies for Atopic Dermatitis: Essential Approaches and Beyond.
    Sala-Cunill A; Lazaro M; Herráez L; Quiñones MD; Moro-Moro M; Sanchez I;
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):379-391. PubMed ID: 30004024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.
    Wang D; Beck LA
    Am J Clin Dermatol; 2016 Oct; 17(5):425-443. PubMed ID: 27371134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm.
    Luger T; De Raeve L; Gelmetti C; Kakourou T; Katsarou A; Lambert J; Morren MA; Oranje A; Ruer M; Serdaroglu S; Torrelo A; Werfel T
    Eur J Dermatol; 2013; 23(6):758-66. PubMed ID: 24185493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and Emerging Biologics for Atopic Dermatitis.
    Baghoomian W; Na C; Simpson EL
    Am J Clin Dermatol; 2020 Aug; 21(4):457-465. PubMed ID: 32323259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial.
    Bostoen J; Bracke S; De Keyser S; Lambert J
    Br J Dermatol; 2012 Nov; 167(5):1025-31. PubMed ID: 22709422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient.
    Gelmetti C; Boralevi F; Seité S; Grimalt R; Humbert P; Luger T; Stalder JF; Taïeb A; Tennstedt D; Garcia Diaz R; Rougier A
    Pediatr Dermatol; 2012; 29(6):714-8. PubMed ID: 23106672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novelties in atopic dermatitis research.
    Ferrer E
    Drug News Perspect; 2008 Oct; 21(8):465-8. PubMed ID: 19034353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.